FOR PREVIEW ONLY (Print)

Shehnaz Hussain, PhD, ScM

Associate Professor, Medicine

Send an Email

Research Office:

Phone:

310-423-6401

Shehnaz Hussain, PhD, ScM

Associate Professor, Medicine

Shehnaz Hussain, PhD, ScM, is an associate professor at Cedars-Sinai Medical Center in the Division of Hematology/Oncology, and at the UCLA Fielding School of Public Health in the Department of Epidemiology. Her research interests are primarily in the molecular epidemiology of cancer. Of specific focus are risk factors that relate to immune function and response, including inherited genetic variation in immune related genes, biomarkers of immune response, and immune-modulating environmental and host factors. Cancers of interest include anogenital cancers, gastrointestinal cancers, skin cancers, and non-Hodgkin lymphoma. The overarching goals of Dr. Hussain's current research projects are to gain a better understanding of the biological underpinnings and pathogenesis of cancer and to identify biomarkers for early detection. Dr. Hussain completed her B.S. in Biology from the Colorado College, M.S. in Epidemiology from the Johns Hopkins University, and Ph.D. in Epidemiology from the University of Washington. She subsequently completed a postdoctoral fellowship at the Karolinska Institute in Sweden, and a second fellowship at the University of California, Los Angeles.

  • Undergraduate: Colorado College, 1999
  • Master's: Johns Hopkins University, 2002
  • Doctorate: University of Washington, 2006

Click here for a list of peer-reviewed publications.

  • Thapa DR, Hussain SK, Tran WC, D'souza G, Bream JH, Achenback CJ, Ayyavoo V,Detels R, Martínez-Maza O. Serum microRNAs in HIV-infected individuals aspre-diagnosis biomarkers for AIDS-related non-Hodgkin lymphomas (AIDS-NHL). JAcquir Immune Defic Syndr. 2014 Mar 26. [Epub ahead of print] PubMed PMID:24675587.
  • Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, WeisenburgerDD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphomasubtypes after solid organ transplantation in the United States. Br J Cancer.2013 Jul 9;109(1):280-288. doi: 10.1038/bjc.2013.294. Epub 2013 Jun 11. PubMedPMID: 23756857; PubMed Central PMCID: PMC3708563.
  • Hussain SK, Hessol NA, Levine AM, Breen EC, Anastos K, Cohen M, D'Souza G,Gustafson DR, Silver S, Martínez-Maza O. Serum biomarkers of immune activationand subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2084-2093. doi:10.1158/1055-9965.EPI-13-0614. Epub 2013 Sep 17. PubMed PMID: 24045923; PubMed Central PMCID: PMC3833437.
  • Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, WeisenburgerDD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphomasubtypes after solid organ transplantation in the United States. Br J Cancer.2013 Jul 9;109(1):280-288. doi: 10.1038/bjc.2013.294. Epub 2013 Jun 11. PubMedPMID: 23756857; PubMed Central PMCID: PMC3708563.
  • Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM. Nucleotide variation in IL-10 and IL-12 and theirreceptors and cervical and vulvar cancer risk: a hybrid case-parent triad andcase-control study. Int J Cancer. 2013 Jul;133(1):201-213. doi: 10.1002/ijc.28000.Epub 2013 Feb 12. PubMed PMID: 23280621; PubMed Central PMCID: PMC3833442.

Show moreShow less

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Shehnaz Hussain, PhD, ScM